Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2026)

Camp4 Therapeutics' EPS (Basic) history spans 3 years, with the latest figure at -$0.87 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 101.33% to -$0.87 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.66, a 76.46% increase, with the full-year FY2025 number at -$2.65, up 76.0% from a year prior.
  • EPS (Basic) hit -$0.87 in Q4 2025 for Camp4 Therapeutics, down from -$0.55 in the prior quarter.
  • Over the last five years, EPS (Basic) for CAMP hit a ceiling of $65.46 in Q4 2024 and a floor of -$30.18 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$7.33 across 3 years, with a median of -$12.53 in 2024.
  • Biggest five-year swings in EPS (Basic): soared 316.9% in 2024 and later plummeted 101.33% in 2025.
  • Tracing CAMP's EPS (Basic) over 3 years: stood at -$30.18 in 2023, then skyrocketed by 316.9% to $65.46 in 2024, then plummeted by 101.33% to -$0.87 in 2025.
  • Business Quant data shows EPS (Basic) for CAMP at -$0.87 in Q4 2025, -$0.55 in Q3 2025, and -$0.62 in Q2 2025.